Tourmaline Bio | EFFECT: Others
Tourmaline Bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(9.9%),Peter Kolchinsky(9.9%), etc.
Tourmaline Bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Blue Owl Capital Holdings LP(6.0%)
Tourmaline Bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Viking Global Investors LP(0.0%),Viking Global Opportunities Parent GP LLC(0.0%), etc.
Tourmaline Bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(0%),Deep Track Biotechnology Master Fund, Ltd.(0%), etc.
Tourmaline Bio | SC 13G: Statement of acquisition of beneficial ownership by individuals-Avoro Capital Advisors LLC(8.7%),Behzad Aghazadeh(8.7%)
Tourmaline Bio | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.8%)
Tourmaline Bio | S-3: Registration statement for specified transactions by certain issuers
Tourmaline Bio | 10-Q: Q3 2024 Earnings Report
Tourmaline Bio | 8-K: Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Tourmaline Bio | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.8%)
Tourmaline Bio | 8-K: Current report
Tourmaline Bio | 8-K: Current report
Tourmaline Bio | 8-K: Current report
Tourmaline Bio | 4: Statement of changes in beneficial ownership of securities-Officer Kulkarni Sandeep Chidambar
Tourmaline Bio | 4: Statement of changes in beneficial ownership of securities-Officer Kulkarni Sandeep Chidambar
Tourmaline Bio | 10-Q: Q2 2024 Earnings Report
Tourmaline Bio | 8-K: Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Tourmaline Bio | 4: Statement of changes in beneficial ownership of securities-Officer Robinson Ryan F.
Tourmaline Bio | 8-K: Current report
No Data
No Data